Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The technique effectively shows how human skin and hair cells form into ball-like structures.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

A reliable method was developed to measure aristolochic acid-I in rat blood.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

GLI2 activates GLI1, promoting skin tumor growth and hair development.

The method effectively measures drug impact on DHT levels in prostate treatments.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

The vector successfully directed specific gene expression in hair follicles.

The 3D skin model is better for hair growth research and testing treatments.

The assay effectively detects hormonal activity of certain chemicals.

A new method using gold nanoshells and infrared light effectively delivers siRNA to cancer and stem cells with precision and minimal damage.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

Researchers created a mouse cell line to study hair growth and test hair growth drugs.

Melatonin affects cell growth differently based on its concentration.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

LHX2, with other markers, can identify hair placodes in rats.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.